vs
LINDSAY CORP（LNN）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是LINDSAY CORP的1.3倍（$197.9M vs $150.7M），LINDSAY CORP净利率更高（11.0% vs 6.7%，领先4.3%），REPLIGEN CORP同比增速更快（13.6% vs -6.1%），REPLIGEN CORP自由现金流更多（$17.6M vs $-15.1M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 1.3%）
林赛公司总部位于美国内布拉斯加州奥马哈市，原名林赛制造公司，核心产品为旗下Zimmatic品牌中心枢轴灌溉系统，此外还生产农业机械、工程机械，以及公路与铁路基础设施设备。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
LNN vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.3倍
$150.7M
营收增速更快
RGEN
高出19.8%
-6.1%
净利率更高
LNN
高出4.3%
6.7%
自由现金流更多
RGEN
多$32.6M
$-15.1M
两年增速更快
RGEN
近两年复合增速
1.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $150.7M | $197.9M |
| 净利润 | $16.5M | $13.3M |
| 毛利率 | 33.3% | 52.5% |
| 营业利润率 | 13.0% | 9.0% |
| 净利率 | 11.0% | 6.7% |
| 营收同比 | -6.1% | 13.6% |
| 净利润同比 | -3.7% | 143.9% |
| 每股收益（稀释后） | $1.54 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNNRGEN
| Q4 25 | $150.7M | $197.9M | ||
| Q3 25 | $149.0M | $188.8M | ||
| Q2 25 | $165.7M | $182.4M | ||
| Q1 25 | $183.8M | $169.2M | ||
| Q4 24 | $160.5M | $174.1M | ||
| Q3 24 | $149.4M | $154.9M | ||
| Q2 24 | $133.7M | $154.1M | ||
| Q1 24 | $146.8M | $151.3M |
净利润LNNRGEN
| Q4 25 | $16.5M | $13.3M | ||
| Q3 25 | $10.8M | $14.9M | ||
| Q2 25 | $19.5M | $14.9M | ||
| Q1 25 | $26.6M | $5.8M | ||
| Q4 24 | $17.2M | $-30.3M | ||
| Q3 24 | $12.7M | $-654.0K | ||
| Q2 24 | $20.4M | $3.3M | ||
| Q1 24 | $18.1M | $2.1M |
毛利率LNNRGEN
| Q4 25 | 33.3% | 52.5% | ||
| Q3 25 | 30.0% | 53.2% | ||
| Q2 25 | 32.4% | 50.0% | ||
| Q1 25 | 34.0% | 53.6% | ||
| Q4 24 | 31.1% | 26.1% | ||
| Q3 24 | 30.6% | 50.0% | ||
| Q2 24 | 34.8% | 49.8% | ||
| Q1 24 | 33.3% | 49.5% |
营业利润率LNNRGEN
| Q4 25 | 13.0% | 9.0% | ||
| Q3 25 | 7.6% | 8.9% | ||
| Q2 25 | 14.4% | 7.6% | ||
| Q1 25 | 17.5% | 3.9% | ||
| Q4 24 | 13.0% | -17.7% | ||
| Q3 24 | 9.0% | -5.1% | ||
| Q2 24 | 14.9% | 1.0% | ||
| Q1 24 | 15.1% | 1.3% |
净利率LNNRGEN
| Q4 25 | 11.0% | 6.7% | ||
| Q3 25 | 7.3% | 7.9% | ||
| Q2 25 | 11.8% | 8.2% | ||
| Q1 25 | 14.5% | 3.4% | ||
| Q4 24 | 10.7% | -17.4% | ||
| Q3 24 | 8.5% | -0.4% | ||
| Q2 24 | 15.2% | 2.2% | ||
| Q1 24 | 12.3% | 1.4% |
每股收益（稀释后）LNNRGEN
| Q4 25 | $1.54 | $0.24 | ||
| Q3 25 | $0.99 | $0.26 | ||
| Q2 25 | $1.78 | $0.26 | ||
| Q1 25 | $2.44 | $0.10 | ||
| Q4 24 | $1.57 | $-0.55 | ||
| Q3 24 | $1.16 | $-0.01 | ||
| Q2 24 | $1.85 | $0.06 | ||
| Q1 24 | $1.64 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $199.6M | $767.6M |
| 总债务越低越好 | $115.2M | $542.2M |
| 股东权益账面价值 | $518.2M | $2.1B |
| 总资产 | $828.4M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.22× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资LNNRGEN
| Q4 25 | $199.6M | $767.6M | ||
| Q3 25 | $250.6M | $748.7M | ||
| Q2 25 | $210.8M | $708.9M | ||
| Q1 25 | $186.7M | $697.2M | ||
| Q4 24 | $194.1M | $757.4M | ||
| Q3 24 | $190.9M | $784.0M | ||
| Q2 24 | $152.7M | $809.1M | ||
| Q1 24 | $150.6M | $780.6M |
总债务LNNRGEN
| Q4 25 | $115.2M | $542.2M | ||
| Q3 25 | $115.3M | $537.9M | ||
| Q2 25 | $115.3M | — | ||
| Q1 25 | $115.4M | — | ||
| Q4 24 | $115.4M | $525.6M | ||
| Q3 24 | $115.5M | — | ||
| Q2 24 | $115.5M | — | ||
| Q1 24 | $115.6M | — |
股东权益LNNRGEN
| Q4 25 | $518.2M | $2.1B | ||
| Q3 25 | $532.9M | $2.1B | ||
| Q2 25 | $528.8M | $2.1B | ||
| Q1 25 | $516.4M | $2.0B | ||
| Q4 24 | $488.5M | $2.0B | ||
| Q3 24 | $480.9M | $2.0B | ||
| Q2 24 | $480.0M | $2.0B | ||
| Q1 24 | $483.0M | $2.0B |
总资产LNNRGEN
| Q4 25 | $828.4M | $2.9B | ||
| Q3 25 | $840.8M | $2.9B | ||
| Q2 25 | $840.9M | $2.9B | ||
| Q1 25 | $814.2M | $2.9B | ||
| Q4 24 | $771.0M | $2.8B | ||
| Q3 24 | $760.2M | $2.8B | ||
| Q2 24 | $758.1M | $2.9B | ||
| Q1 24 | $765.3M | $2.8B |
负债/权益比LNNRGEN
| Q4 25 | 0.22× | 0.26× | ||
| Q3 25 | 0.22× | 0.26× | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.24× | 0.27× | ||
| Q3 24 | 0.24× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-597.0K | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-15.1M | $17.6M |
| 自由现金流率自由现金流/营收 | -10.0% | 8.9% |
| 资本支出强度资本支出/营收 | 9.6% | 4.1% |
| 现金转化率经营现金流/净利润 | -0.04× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $62.9M | $93.9M |
8季度趋势，按日历期对齐
经营现金流LNNRGEN
| Q4 25 | $-597.0K | $25.7M | ||
| Q3 25 | $64.0M | $48.1M | ||
| Q2 25 | $35.0M | $28.6M | ||
| Q1 25 | $12.3M | $15.0M | ||
| Q4 24 | $21.6M | $39.2M | ||
| Q3 24 | $53.1M | $49.3M | ||
| Q2 24 | $30.5M | $42.2M | ||
| Q1 24 | $-9.7M | $44.7M |
自由现金流LNNRGEN
| Q4 25 | $-15.1M | $17.6M | ||
| Q3 25 | $49.8M | $43.4M | ||
| Q2 25 | $25.7M | $21.5M | ||
| Q1 25 | $2.5M | $11.4M | ||
| Q4 24 | $12.5M | $33.6M | ||
| Q3 24 | $47.7M | $42.3M | ||
| Q2 24 | $25.8M | $37.4M | ||
| Q1 24 | $-21.6M | $36.4M |
自由现金流率LNNRGEN
| Q4 25 | -10.0% | 8.9% | ||
| Q3 25 | 33.4% | 23.0% | ||
| Q2 25 | 15.5% | 11.8% | ||
| Q1 25 | 1.4% | 6.8% | ||
| Q4 24 | 7.8% | 19.3% | ||
| Q3 24 | 31.9% | 27.3% | ||
| Q2 24 | 19.3% | 24.3% | ||
| Q1 24 | -14.7% | 24.0% |
资本支出强度LNNRGEN
| Q4 25 | 9.6% | 4.1% | ||
| Q3 25 | 9.6% | 2.5% | ||
| Q2 25 | 5.6% | 3.9% | ||
| Q1 25 | 5.3% | 2.1% | ||
| Q4 24 | 5.7% | 3.2% | ||
| Q3 24 | 3.6% | 4.5% | ||
| Q2 24 | 3.6% | 3.1% | ||
| Q1 24 | 8.1% | 5.5% |
现金转化率LNNRGEN
| Q4 25 | -0.04× | 1.93× | ||
| Q3 25 | 5.92× | 3.23× | ||
| Q2 25 | 1.79× | 1.92× | ||
| Q1 25 | 0.46× | 2.57× | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 4.17× | — | ||
| Q2 24 | 1.50× | 12.70× | ||
| Q1 24 | -0.54× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LNN
| Transferred At Point In Time | $133.2M | 88% |
| Infrastructure | $13.4M | 9% |
| Transferred Over Time | $8.0M | 5% |
RGEN
暂无分部数据
